Strength in Synergy.
Powerful Impact.
Advancing the Future of Cancer Therapies
We founded ALX Oncology to develop highly differentiated medicines that fully deliver on the promise of innovative cancer therapies.
Learn about our differentiated scientific approaches.
Our ScienceUnleashing the Full Power of the Immune System
We’re exploring the potential of evorpacept to become a cornerstone therapy upon which the future of immuno-oncology can be built.
Development Plan
Bringing Antibody-Drug Conjugates to EGFR-Positive Tumors
We designed ALX2004 to optimize the cancer-killing potential of antibody-drug conjugates (ADCs) against EGFR-positive tumors.
Development Plan
Leading the Evolution
Science driven with a tenacious focus, our team is uniquely capable and committed to taking cancer therapies to the next level.
Meet Our Leaders
ALX Oncology is a clinical-stage biopharmaceutical company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives.
Recent Announcements
Loading...